Epithelial lesions in prophylactic mastectomy specimens from women with BRCA mutations

Cancer

Volumn 97, Issue 7, 2003, Pages 1601-1608

  Kauff, Noah D ^a   Brogi, Edi ^a   Scheuer, Lauren ^a   Pathak, Dorothy R ^b   Borgen, Patrick I ^a   Hudis, Clifford A ^a   Offit, Kenneth ^a   Robson, Mark E ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

BRCA1, BRCA2, hereditary breast carcinoma, pathology; Prophylactic mastectomy

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN; UVOMORULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; CONTROLLED STUDY; EPITHELIUM; FEMALE; FOLLOW UP; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPEROXIDASE STAINING; MAMMOGRAPHY; MASTECTOMY; ONCOGENE; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS;

ADULT; BIOPSY; BREAST; BREAST NEOPLASMS; CARCINOMA IN SITU; FEMALE; GENES, BRCA1; HUMANS; MASTECTOMY; MIDDLE AGED; MUTATION;

EID: 0037378455     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11225     Document Type: Article

References (30)

1. Brekelmans CT, Seynaeve C, Bartels CC, et al. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J Clin Oncol. 2001;19:924-930.
2. Scheuer L, Kauff ND, Robson M, et al. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol. 2002;20:1260-1268.
3. Sun CC, Lenoir G, Lynch H, Narod SA. In-situ breast cancer and BRCA1 [letter]. Lancet. 1996;348:408.
4. Jacquemeir J, Eisinger F, Guinebretiere JM, Stoppa-Lyonnet D, Sobol H. Intraductal component and BRCA1-associated breast cancer [letter]. Lancet. 1996;348:1098.
5. Breast Cancer Linkage Consortium. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet. 1997;349:1505-1510.
6. Bartow SA, Pathak DR, Black WC, Key CR, Teaf SR. Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study. Cancer. 1987;60:2751-2760.
7. Page DL, Anderson TJ. Diagnostic histopathology of the breast. Edinburgh: Churchill Livingstone, 1987.
8. Page DL, Rogers LW. Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. Hum Pathol. 1992;23:1095-1097.
9. Fraser JL, Raza S, Chorny K, Connolly JL, Schnitt SJ. Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications. Am J Surg Pathol. 1998;22:1521-1527.
10. Rosen PP. Rosen's breast pathology, 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 2001.
11. Altman F. Differences in proportions - practical statistics for medical research. London: Chapman Hall, 1994:268.
12. Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer. 1985;55:2698-2708.
13. Dupont WD, Parl FF, Hartmann WH, et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer. 1993;71:1258-1265.
14. Page DL, Dupont WD, Rogers LW, Landenberger M. Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer. 1982;49:751-758.
15. Rosen PP, Braun DW Jr., Kinne DE. The clinical significance of pre-invasive breast carcinoma. Cancer. 1980;46:919-925.
16. Jakobs TW, Pliss N, Kouria G, Schnitt SJ. Carcinomas in situ of the breast with indeterminate features: role of E-cadherin staining in categorization. Am J Surg Pathol. 2001;25:229-236.
17. Maluf HM, Swanson PE, Koerner FC. Solid low-grade in situ carcinoma of the breast: role of associated lesions and E-cadherin in differential diagnosis. Am J Surg Pathol. 2001;25:237-244.
18. Stoutjesdijk MJ, Boetes C, Jager GJ, et al. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst. 2001;93:1095-1102.
19. Warner E, Plewes DB, Shumak RS, et al. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol. 2001;19:3524-3531.
20. Robson ME, Boyd J, Borgen PI, Cody HS III. Hereditary breast cancer. Curr Prob Surg. 2001;38:377-480.
21. Skolnick MH, Cannon-Albright LA, Goldgar DE, et al. Inheritance of proliferative breast disease in breast cancer kindreds. Science. 1990;250:1715-1720.
22. Marshall CJ, Schumann GB, Ward JH, et al. Cytologic identification of clinically occult proliferative breast disease in women with a family history of breast cancer. Am J Clin Pathol. 1991;95:157-165.
23. Fabian CJ, Kimler BF, Zalles CM, et al. Short-term breast cancer prediction by random peri-areolar fine-needle aspiration cytology and the Gail risk model. J Natl Cancer Inst. 2000;92:1217-1227.
24. Khurana KK, Loosmann A, Numann PJ, Khan SA. Prophylactic mastectomy: pathologic findings in high-risk patients. Arch Pathol Lab Med. 2000;124:378-381.
25. Meijers-Heijboer H, van Geel B, van Putten WL, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med. 2001;345:159-164.
26. Kauff ND, Satagopan JM, Robson ME, et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med. 2002;346:1609-1615.
27. Rebbeck TR, Lynch HT, Neuhausen SL, et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med. 2002;346:1616-1622.
28. Narod SA, Brunet JS, Ghadirian P, et al. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. Lancet. 2000;356:1876-1881.
29. King MC, Wieand S, Hale K, et al. Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. JAMA. 2001;286:2251-2256.
30. Lakhani SR. The transition from hyperplasia to invasive carcinoma of the breast. J Pathol. 1999;187:272-278.